$318.66
-0.04[-0.01%]
At close: May 28
$318.66
0[0.00%]
After Hours: 4:00PM EDT
HCA Healthcare
(NYSE:HCA)HCA Healthcare Stock (NYSE:HCA), Insider Trading Activity
HCA Healthcare: Insider buying and selling updated today.
Shares Outstanding
261.914M%
Insider Shares Owned
3.584M
Insider Percentage Owned
1.36%
Institutional Shares Held
106.149M
Institutional Percentage Held
40.5%
| May 20, 2024 | Kathleen Whalen | SVP & CHIEF ETHICS OFFICER | -1.34K | $218.69 | -$1.44M | SELL | -10.59% | 11.318K | May 16 - May 17 | View |
| May 17, 2024 | Kathryn Torres | SVP-PAYER CONTRACTING & ALIGN. | -1.863K | $326.18 | -$607.67K | SELL | -8.68% | 19.612K | May 15 | View |
| May 13, 2024 | Michael Cuffe | EVP AND CHIEF CLINICAL OFFICER | -6.311K | $316.88 | -$2.00M | SELL | -17.56% | 29.6239692K | May 09 | View |
| May 13, 2024 | Jeffrey Cohen | SVP-GOVERNMENT RELATIONS | -1.65K | $313.00 | -$516.45K | SELL | -24.14% | 5.185K | May 09 | View |
| May 08, 2024 | Michael Cuffe | EVP AND CHIEF CLINICAL OFFICER | 211 | $226.44 | -$1.78M | SELL-OPTIONS | 0.59% | 35.9349692K | May 06 - May 08 | View |
| May 06, 2024 | Kathryn Torres | SVP-PAYER CONTRACTING & ALIGN. | -1.863K | $312.00 | -$581.26K | SELL | -7.98% | 21.475K | May 02 - May 03 | View |
| Mar 20, 2024 | Chad Wasserman | SVP AND CIO | -344 | $214.35 | -$588.08K | SELL | -17.91% | 1.5763102K | Mar 18 - Mar 20 | View |
| Feb 13, 2024 | Kathleen Whalen | SVP & CHIEF ETHICS OFFICER | -4.262K | $306.21 | -$1.31M | SELL | -29.37% | 10.25K | Feb 09 | View |
| Feb 07, 2024 | Christopher Wyatt | SVP & CONTROLLER | -4K | $312.42 | -$1.25M | SELL | -9.67% | 37.383K | Feb 05 | View |
| Feb 06, 2024 | BILL RUTHERFORD | CFO AND EVP | 3.273K | $189.73 | -$3.52M | SELL-OPTIONS | 21.57% | 18.448K | Feb 02 - Feb 06 | View |
| Feb 06, 2024 | Sammie Mosier | SVP & CHIEF NURSE EXECUTIVE | -371 | $270.92 | -$650.35K | SELL | -4.63% | 7.646K | Feb 02 - Feb 05 | View |
| Feb 06, 2024 | Chad Wasserman | SVP AND CIO | -563 | $311.90 | -$215.21K | SELL | -59.75% | 379.3102 | Feb 02 - Feb 03 | View |
| Feb 02, 2024 | Kathryn Torres | SVP-PAYER CONTRACTING & ALIGN. | -135 | $248.32 | -$1.71M | SELL | -0.68% | 19.625K | Jan 31 - Feb 01 | View |
| Feb 02, 2024 | Michael Cuffe | EVP AND CHIEF CLINICAL OFFICER | -3.928K | $306.79 | -$981.73K | SELL | -13.61% | 24.9289672K | Jan 31 | View |
| Aug 16, 2023 | Kathryn Torres | SVP-PAYER CONTRACTING & ALIGN. | -5.204K | $269.12 | -$1.40M | SELL | -20.85% | 19.76K | Aug 14 | View |
| Aug 15, 2023 | Jeffrey Cohen | SVP-GOVERNMENT RELATIONS | -1.5K | $270.00 | -$405.00K | SELL | -25.36% | 4.414K | Aug 11 | View |
| Aug 07, 2023 | Kathleen Whalen | SVP & CHIEF ETHICS OFFICER | -2.916K | $270.00 | -$787.32K | SELL | -22.15% | 10.25K | Aug 03 | View |
| May 02, 2023 | Michael Cuffe | EVP AND CHIEF CLINICAL OFFICER | -12.556K | $284.44 | -$3.57M | SELL | -30.37% | 28.783356899999998K | Apr 28 | View |
| May 02, 2023 | Erol Akdamar | GROUP PRESIDENT | -3.5K | $285.00 | -$997.50K | SELL | -3.30% | 102.484K | Apr 28 - May 01 | View |
| Apr 26, 2023 | Kathryn Torres | SVP-PAYER CONTRACTING & ALIGN. | -4.473K | $288.38 | -$1.29M | SELL | -16.74% | 22.243K | Apr 24 | View |
| Apr 14, 2023 | Martin Paslick | SVP AND CIO | 0 | $177.73 | -$1.21M | SELL-OPTIONS | 0.00% | 88.642K | Apr 12 - Apr 14 | View |
| Apr 12, 2023 | Martin Paslick | SVP AND CIO | -2.539K | $270.00 | -$685.53K | SELL | -2.78% | 88.642K | Apr 10 | View |
| Apr 06, 2023 | Martin Paslick | SVP AND CIO | -495 | $175.16 | -$1.25M | SELL | -0.54% | 91.181K | Apr 04 - Apr 05 | View |
| Feb 22, 2023 | Kathleen Whalen | SVP & CHIEF ETHICS OFFICER | 1.47K | $263.27 | -$813.51K | GRANT | 12.57% | 13.166K | Feb 17 | View |
| Feb 09, 2023 | Jennifer Berres | SVP & CHIEF HUMAN RES. OFFICER | -4K | $255.23 | -$1.02M | SELL | -35.11% | 7.392K | Feb 07 | View |
| Feb 07, 2023 | Deborah Reiner | SVP - MKTG. & COMMUNICATIONS | -7.941K | $257.61 | -$2.05M | SELL | -100.00% | 0 | Feb 03 | View |
| Feb 06, 2023 | Erol Akdamar | GROUP PRESIDENT | 2.068K | $151.81 | -$1.38M | SELL-OPTIONS | 2.12% | 99.794K | Feb 02 - Feb 03 | View |
| Feb 03, 2023 | BILL RUTHERFORD | CFO AND EVP | -895 | $164.58 | -$12.44M | SELL | -0.88% | 100.272K | Feb 01 - Feb 03 | View |
| Feb 01, 2023 | Christopher Wyatt | SVP & CONTROLLER | 208 | $167.63 | -$1.91M | SELL-OPTIONS | 0.65% | 32.392K | Jan 30 - Feb 01 | View |
| Feb 01, 2023 | Martin Paslick | SVP AND CIO | -1K | $256.95 | -$256.95K | SELL | -1.47% | 66.999K | Feb 01 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.